Pravastatin inhibits farnesol production inCandida albicansand improves survival in a mouse model of systemic candidiasis

Statins in Candidemia: clinical outcomes from a matched cohort study

(2010) Graeme N Forrest et al.   BMC INFECTIOUS DISEASES

Candida albicans cell wall components and farnesol stimulate the expression of both inflammatory and regulatory cytokines in the murine RAW264.7 macrophage cell line

(2010) Suman Ghosh et al.   FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY

In vitro synergistic interactions of the effects of various statins and azoles against some clinically important fungi

(2010) Ildikó Nyilasi et al.   FEMS MICROBIOLOGY LETTERS

Effect of  -1,6-Glucan Inhibitors on the Invasion Process of Candida albicans: Potential Mechanism of Their In Vivo Efficacy

(2009) A. Kitamura et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Are Statins Applicable for the Prevention and Treatment of Zygomycosis?

(2009) László Galgóczy et al.   CLINICAL INFECTIOUS DISEASES

Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance Registry

(2009) David L. Horn et al.   CLINICAL INFECTIOUS DISEASES

Novel antifungal agents, targets or therapeutic strategies for the treatment of invasive fungal diseases: a review of the literature (2005-2009)

(2009) Ana Espinel-Ingroff   REVISTA IBEROAMERICANA DE MICOLOGIA

Discovery of a Small-Molecule Inhibitor of  -1,6-Glucan Synthesis

(2008) A. Kitamura et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Statins and sepsis

(2008) F Gao et al.   BRITISH JOURNAL OF ANAESTHESIA